Regulation of TH17 and regulatory T cells in patients with Behçet disease - 28/08/11
Key words : Behçet disease, TH17, regulatory T cell
Le texte complet de cet article est disponible en PDF.
Disclosure of potential conflict of interest: C. A. Akdis receives research support from Novartis, Stallergenes, the Swiss National Science Foundation, the Global Allergy and Asthma European Network (GA2LEN), and the Christine Kuhne Center for Allergy Research; has consultant arrangements with Actellion, Aventis, and Allergopharma; is a fellow and interest group member of the American Academy of Allergy, Asthma & Immunology; is Vice President of the European Academy of Allergy and Clinical Immunology; and is a former committee member of GA2LEN. The rest of the authors have declared that they have no conflict of interest. |
Vol 128 - N° 3
P. 665-666 - septembre 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?